PSCM
RDY icon

Prince Street Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Prince Street Capital Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-43,000
Closed -$475K – 34
2015
Q2 		$475K Sell
43,000
-134,000
-76% -$1.48M 0.17% 24
2015
Q1 		$2.02M Buy
+177,000
New +$1.88M 1.96% 14

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OAM
Origin Asset Management London, United Kingdom $43.5M AUM 31.63% 1-Year Est. Return

Prince Street Capital Management's RDY Position: Q3 2015 in Review

Prince Street Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q3 2015, closing a stake of 43,000 shares — an estimated $475K sold.

Prince Street Capital Management first reported a position in RDY in Q1 2015 and held it in 2 quarters. The position peaked at $2.02M in Q1 2015. 206 funds tracked by Wall St. Rank hold RDY as of Q3 2015.

  • Prince Street Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q3 2015 after selling out during the quarter.
  • Prince Street Capital Management sold 43,000 Dr. Reddy's Laboratories shares in Q3 2015, an estimated $475K.
  • Prince Street Capital Management first reported a position in Dr. Reddy's Laboratories in Q1 2015 and held it in 2 quarters.
  • Prince Street Capital Management's Dr. Reddy's Laboratories position peaked at $2.02M in Q1 2015.
  • 206 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2015.

Based on Prince Street Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.